Related Experiment Video
Updated: Aug 2, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 29, 2010
[Pathogenesis of colorectal carcinoma]
A Reinacher-Schick1, W Schmiegel
1Medizinische Klinik, Knappschaftskrankenhaus, Ruhr-Universität Bochum.
Colorectal cancer (CRC) develops through distinct pathways: the "suppressor pathway" involving chromosomal instability and tumor suppressor gene inactivation, and the "mutator pathway" characterized by DNA-level microsatellite instability (MSI). A "serrated pathway" also contributes to MSI-driven CRC development.
Area of Science:
- Molecular biology
- Gastroenterology
- Oncology
Context:
- Colorectal carcinoma (CRC) pathogenesis is increasingly understood through distinct molecular pathways.
- The traditional adenoma-carcinoma sequence, or
Purpose:
- To review the molecular genetic alterations and clinicopathological features of different colorectal cancer (CRC) carcinogenesis pathways.
- To elucidate the roles of the
Summary:
- Colorectal cancer (CRC) develops via at least three pathways: the
Impact:
- Understanding these distinct pathways aids in diagnosing CRC subtypes.
- This knowledge can inform targeted therapeutic strategies for colorectal cancer.
- Highlights the heterogeneity in colorectal cancer development.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Gastritis II: Pathophysiology
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

